Exelixis Inc. / Swedish Orphan Biovitrum AB / Savient Pharmaceuticals Inc. / Amgen / On 19 February / Biogen Idec / Financial Review / Pfizer / ReFacto Manufacturing / Geoffrey McDonough / Sobi Inc. / PharmaSwiss / /
Continent
North America / Europe / /
Country
Germany / Netherlands / Italy / Sweden / Norway / Belgium / Turkey / France / Austria / United States / Portugal / Liechtenstein / United Kingdom / Luxembourg / Finland / Spain / Ireland / Denmark / /
Currency
SEK / /
Event
Business Partnership / FDA Phase / Labor Issues / /
Facility
building of Kineret / /
IndustryTerm
important products / partner network / microbial site / treatment of Neonatal-Onset Multisystem Inflammatory Disease / drug manufacturing / manufacturing / technology transfer / /
MedicalCondition
Haemophilia / neonatal seizures / Rheumatoid Arthritis / Haemophilia A / rare disease / Haemophilia B / Medullary Thyroid Cancer / Inflammation / /
Organization
European Association for Haemophilia and Allied Disorders / Neonatal Intensive Care Unit / European Medicines Agency / US Food and Drug Administration / European Union / /
Person
Geoffrey McDonough / Boehringer Ingelheim / Bruce Faulkner / /
Position
Contents CEO / CEO / President and CEO / THE FIRST QUARTER CEO / CEO and President / /
REPORT FOR THE FIRST QUARTER • 2013 Pioneer in Rare Diseases SOBI REPORT FOR THE FIRST QUARTER |TABLE OF CONTENTS 1